公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2013 | Autophagy regulates TNFα-mediated joint destruction in experimental arthritis | NENG-YU LIN ; Beyer C.; Gießl A.; Kireva T.; Scholtysek C.; Uderhardt S.; Enrique Munoz L.; Dees C.; Distler A.; Wirtz S.; Krönke G.; Spencer B.; Distler O.; Schett G.; Distler J.H.W. | Annals of the Rheumatic Diseases | 227 | 206 | |
2013 | Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis | Beyer C.; Reichert H.; Akan H.; Mallano T.; Schramm A.; Dees C.; Palumbo-Zerr K.; NENG-YU LIN ; Distler A.; Gelse K.; Varga J.; Distler O.; Schett G.; Distler J.H.W. | Annals of the Rheumatic Diseases | 101 | 94 | |
2014 | Inactivation of evenness interrupted (EVI) reduces experimental fibrosis by combined inhibition of canonical and non-canonical Wnt signalling | Distler A.; Ziemer C.; Beyer C.; NENG-YU LIN ; Chen C.-W.; Palumbo-Zerr K.; Dees C.; Weidemann A.; Distler O.; Schett G.; Distler J.H.W. | Annals of the Rheumatic Diseases | 26 | 27 | |
2013 | Inactivation of tankyrases reduces experimental fibrosis by inhibiting canonical Wnt signalling | Distler A.; Deloch L.; Huang J.; Dees C.; NENG-YU LIN ; Palumbo-Zerr K.; Beyer C.; Weidemann A.; Distler O.; Schett G.; Distler J.H.W. | Annals of the Rheumatic Diseases | 70 | 66 | |
2015 | Inhibition of casein kinase II reduces TGFβ induced fibroblast activation and ameliorates experimental fibrosis | Zhang Y.; Dees C.; Beyer C.; NENG-YU LIN ; Distler A.; Zerr P.; Palumbo K.; Susok L.; Kreuter A.; Distler O.; Schett G.; Distler J.H.W.; Kvien T.K. | Annals of the Rheumatic Diseases | 41 | 36 | |
2016 | Inhibition of Notch1 promotes hedgehog signalling in a HES1-dependent manner in chondrocytes and exacerbates experimental osteoarthritis | NENG-YU LIN ; Distler A.; Beyer C.; Philipi-Schöbinger A.; Breda S.; Dees C.; Stock M.; Tomcik M.; Niemeier A.; Dell'Accio F.; Gelse K.; Mattson M.P.; Schett G.; Distler J.H. | Annals of the Rheumatic Diseases | 35 | 29 | |
2014 | The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis | Dees C.; Schlottmann I.; Funke R.; Distler A.; Palumbo-Zerr K.; Zerr P.; NENG-YU LIN ; Beyer C.; Distler O.; Schett G.; Distler J.H.W. | Annals of the Rheumatic Diseases | 164 | 140 |